On October 5, 2023, Aion Therapeutic Inc. closed the transaction. The company has issued 21,500,000 units at a price of CAD 0.01 per unit, for gross proceeds of CAD 215,000 in its second tranche closing. Including the first tranche of the unit offering, the company has issued a total of 64,250,000 units for total gross proceeds of CAD 642,500 in the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | -25.00% | -25.00% | -25.00% |
1st Jan change | Capi. | |
---|---|---|
-25.00% | 6.01M | |
+37.08% | 5.92B | |
-17.43% | 4.51B | |
-9.46% | 3.15B | |
+0.51% | 3.1B | |
-3.53% | 2.42B | |
+41.15% | 1.97B | |
-5.15% | 1.68B | |
+0.09% | 1.65B | |
-10.38% | 1.53B |
- Stock Market
- Equities
- AION Stock
- News Aion Therapeutic Inc.
- Aion Therapeutic Inc. announced that it has received CAD 0.6425 million in funding